Swart JF, de Roock S, Nievelstein RJ, et al. Safety and efficacy of intravenous administration of bone-marrow derived mesenchymal stromal cells in therapy refractory juvenile idiopathic arthritis patients, a phase ib/iia pilot-study. EULAR 2018. Abstract OP0203.
TREAT EARLIER-studie: wel mijlpaal, geen onmiddellijke aanpassing klinische praktijk
nov 2022 | Artritis, RA